×
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Artificial Heart Market Analysis

ID: MRFR/HC/6513-HCR
90 Pages
Rahul Gotadki
October 2025

Artificial Heart Market Research Report Information by Type (Heart-Lung Machine, Mechanical Heart, Total Artificial Hearts, Ventricular Assist Devices (VADs)), End User (Hospitals & Clinics, Specialty Centers) and Region (Americas, Europe, Asia-Pacific, Middle East Africa) - Forecast till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Artificial Heart Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Market Analysis

In-depth Analysis of Artificial Heart Market Industry Landscape

The artificial heart market is witnessing dynamic changes driven by advancements in medical technology and an increasing prevalence of cardiovascular diseases globally. This market, aimed at providing life-saving solutions for individuals with heart failure, is characterized by several key dynamics. It is technological innovation that has opened the market for artificial heart; it forms a vital factor of this market. This research and development targets at improving the resistance capacity, effectiveness, and biocompatibility of artificial hearts. The fusion of substances as titanium, and advanced pumping technologies contribute to the emergence of even more advanced artificial heart designs. The market dynamics are profoundly affected by the growing cardiovascular disease and particularly, heart failure incidences. The growing number of aging population and the heart related factors spilling over from life style diseases, the need for artificial hearts as a therapeutic alternative is quickly moving. The rising target population drives market growth. The feature with regard to the competitive landscape of this market is that a few leading companies are engaged in investing significant amount on research and development to get an advantage. Collaborations, mergers and acquisitions are the most widely used means to increase market presence of the companies and enrich their product lines which are helping in giving thrust to overall dynamism of artificial heart market. Geographic differences in the quality of infrastructure related to healthcare, patient populations and surrounding regulatory environment also impact on existing market dynamics. Better medical facilities in the developed regions and poor accessibility or awareness towards HIV AIDS problems, as observed in developing countries, can be factors that hinder adoption comparatively with less rapidly than developed nations. Artificial hearths combined with digital health technologies in major developments that change the market dynamics rapidly. Telemonitoring, data analytics solutions for patient care based on connectivity solutions are gradually improving patients’ lifestyle and provide valuable insight to the health professionals which in turn is pushing the field of telehealth. The trends within the market indicate a move in consumer orientation. Customization of artificial heart solutions according to needs and preferences of individual patients is becoming a more important issue in this topic. This patient-centered approach does more than just improve the satisfaction of patients, but also becomes a factor that brings better clinical results. The artificial heart market is poised for continued growth with the convergence of technological innovation, increased awareness, and a growing patient population. Overcoming affordability challenges, addressing long-term reliability concerns, and navigating complex regulatory landscapes will be crucial for sustained market expansion in the years to come.

Author
Rahul Gotadki
Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

Leave a Comment

FAQs

What was the valuation in 2030?

The valuation was USD 4.98 billion.

What is the predicted CAGR for the Artificial Heart Market for the forecast period (2022-2030)?

The predicted CAGR would be 14.3%.

What could slow down market growth?

The high cost of the procedure and regulations regarding the process can slow down the growth.

Which type to lead the market?

The mechanical heart segment has the chance to record a higher CAGR.

Which region would take charge of the artificial heart market?

The Americas market would dominate the global field.

Market Summary

As per MRFR analysis, the Artificial Heart Market Size was estimated at 2581.55 USD Million in 2024. The Artificial Heart industry is projected to grow from 2841.4 USD Million in 2025 to 6635.94 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 8.92% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Artificial Heart Market is poised for substantial growth driven by technological advancements and increasing healthcare investments.

  • North America remains the largest market for artificial hearts, driven by advanced healthcare infrastructure and high patient awareness. The Asia-Pacific region is emerging as the fastest-growing market, fueled by rising healthcare investments and a growing aging population. The cardiac replacement segment dominates the market, while heart failure management is rapidly gaining traction due to increasing patient needs. Key market drivers include the rising incidence of cardiovascular diseases and technological innovations in artificial hearts.

Market Size & Forecast

2024 Market Size 2581.55 (USD Million)
2035 Market Size 6635.94 (USD Million)
CAGR (2025 - 2035) 8.92%
Largest Regional Market Share in 2024 North America

Major Players

<p><a href="https://www.structuralheart.abbott/int/">Abbott Laboratories </a>(US), Medtronic (US), Boston Scientific (US), Cleveland Heart (US), <a href="https://www.carmatsa.com/en/press-release/carmat-announces-first-implant-total-artificial-heart-female-recipient/">Carmen Health </a>(US), SynCardia Systems (US), Jarvik Heart (US), Aortech International (GB), CorWave (FR)</p>

Market Trends

The Artificial Heart Market is currently experiencing a transformative phase, driven by advancements in technology and increasing demand for innovative cardiac solutions. As the prevalence of heart diseases continues to rise, the need for effective treatment options becomes more pressing. This market is characterized by a growing focus on biocompatible materials and miniaturization of devices, which enhance patient comfort and improve outcomes. Furthermore, the integration of artificial intelligence in monitoring and managing heart health appears to be gaining traction, potentially revolutionizing patient care. In addition, the regulatory landscape is evolving, with authorities increasingly recognizing the importance of artificial hearts as viable alternatives to traditional transplants. This shift may lead to expedited approval processes for new devices, fostering innovation and competition among manufacturers. As the Artificial Heart Market continues to expand, collaboration between medical professionals, engineers, and researchers is likely to play a crucial role in developing next-generation solutions that address the diverse needs of patients. The future of this market seems promising, with ongoing research and development paving the way for enhanced therapies and improved quality of life for individuals with severe cardiac conditions.

Technological Advancements

The Artificial Heart Market is witnessing rapid technological advancements that enhance device performance and patient outcomes. Innovations in materials science and engineering are leading to the development of lighter, more durable, and biocompatible artificial hearts. These improvements not only increase the longevity of devices but also reduce the risk of complications, thereby making them more appealing to both patients and healthcare providers.

Regulatory Changes

Recent changes in regulatory frameworks are influencing the Artificial Heart Market by streamlining the approval process for new devices. Regulatory bodies are increasingly recognizing the potential of artificial hearts as effective treatment options, which may lead to faster market entry for innovative products. This shift could encourage manufacturers to invest in research and development, ultimately benefiting patients with advanced heart conditions.

Patient-Centric Approaches

There is a growing emphasis on patient-centric approaches within the Artificial Heart Market, focusing on personalized treatment plans and improved patient experiences. Manufacturers are increasingly considering patient feedback in the design and functionality of artificial hearts, aiming to enhance comfort and usability. This trend reflects a broader movement towards tailoring medical solutions to individual needs, which may lead to better adherence and outcomes.

Artificial Heart Market Market Drivers

Rising Prevalence of Cardiovascular Diseases

The increasing incidence of cardiovascular diseases globally is a primary driver for the Global Artificial Heart Market Industry. As heart-related ailments continue to escalate, the demand for advanced cardiac solutions, including artificial hearts, is likely to rise. In 2024, the market is projected to reach 5 USD Billion, reflecting the urgent need for innovative treatments. This trend is expected to persist as the World Health Organization indicates that cardiovascular diseases remain the leading cause of death worldwide. Consequently, healthcare systems are compelled to invest in artificial heart technologies to address this growing health crisis.

Market Segment Insights

By Application: Cardiac Replacement (Largest) vs. Heart Failure Management (Fastest-Growing)

<p>The Artificial Heart Market shows a diverse application distribution among its core segments. Currently, Cardiac Replacement holds the largest share, primarily due to its established technology and widespread adoption across healthcare facilities. Other segments like Cardiac Support and Heart Valve Replacement also play critical roles, but they do not match the dominant position of Cardiac Replacement, which benefits from ongoing innovations and extensive clinical use. Heart Failure Management, while smaller traditionally, is witnessing rapid adoption as new therapies and devices emerge to address this chronic condition.</p>

<p>Cardiac Replacement: Dominant vs. Heart Failure Management: Emerging</p>

<p>Cardiac Replacement technology remains at the forefront of the Artificial Heart Market, representing a well-established category characterized by advanced implantable devices designed to replace the failing heart. Major manufacturers have invested heavily in research and development to enhance the efficiency and longevity of these devices, ensuring their dominance. On the other hand, Heart Failure Management is an emerging segment that is rapidly gaining traction as awareness about heart diseases increases. Innovations such as wearable devices and <a href="https://www.marketresearchfuture.com/reports/telehealth-market-900">telehealth</a> solutions are propelling this segment forward, making it an important area of growth for future developments in the artificial heart field.</p>

By Type: Total Artificial Heart (Largest) vs. Ventricular Assist Device (Fastest-Growing)

<p>The Artificial Heart Market is marked by a diverse range of segment values, including Total Artificial Heart, Partial Artificial Heart, Ventricular Assist Devices (VAD), and Biventricular Assist Devices (BiVAD). Among these, the Total Artificial Heart stands out as the largest segment, commanding significant attention due to increasing patient needs globally. Moreover, the Ventricular Assist Device segment is rapidly gaining traction, driven by technological advancements and an expanding base of heart failure patients requiring mechanical circulatory support. Growth trends within this market reveal that the demand for both Total Artificial Hearts and VADs is rising, as healthcare providers recognize their essential roles in treating severe heart conditions. The aging population and higher incidence rates of cardiovascular diseases are pivotal drivers fueling market expansion. Additionally, innovations in device technology aim to improve patient outcomes and prolong device longevity, further enhancing their appeal to both clinicians and patients alike.</p>

<p>Device: Total Artificial Heart (Dominant) vs. Ventricular Assist Device (Emerging)</p>

<p>The Total Artificial Heart represents a dominant force within the Artificial Heart Market, providing a comprehensive solution for patients with end-stage heart failure. Its design allows for a complete replacement of the heart, ensuring essential functions are maintained. On the other hand, Ventricular Assist Devices are emerging as critical tools for patients awaiting heart transplants or those not candidates for transplant altogether. These devices assist the heart&rsquo;s function, thus enabling patients to maintain a better quality of life. As innovations continue to evolve in both areas, the classification of Ventricular Assist Devices as an emerging segment underscores the potential for significant growth driven by technological enhancements, increased investment, and heightened awareness among healthcare professionals.</p>

By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

<p>The artificial heart market is primarily dominated by hospitals, which account for a significant share due to their capacity for advanced surgical procedures and comprehensive post-operative care. Ambulatory Surgical Centers (ASCs) are also expanding their presence in this market segment, though their share is smaller compared to hospitals. Home care settings represent a niche market but are gaining traction as technology advances and patient preferences shift toward home-based care. The growth of the artificial heart market is shaped by various factors. Hospitals remain the primary end user as they adopt cutting-edge technologies and innovations in cardiac care. Meanwhile, ASCs are experiencing rapid growth, driven by increased patient volume and the efficient delivery of surgical services. Home care settings are emerging as a viable option, bolstered by advancements in telemedicine and home-based monitoring, enabling patients to receive care without lengthy hospital stays.</p>

<p>Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)</p>

<p>Hospitals play a dominant role in the artificial heart market due to their ability to invest in advanced technologies and provide specialized surgical care. They offer state-of-the-art facilities, highly trained personnel, and comprehensive aftercare services necessary for heart transplant patients. The extensive resources available in hospitals also facilitate <a href="https://www.marketresearchfuture.com/reports/clinical-trials-market-7787">clinical trials</a> and research, ensuring that they stay at the forefront of innovations. On the other hand, Ambulatory Surgical Centers (ASCs) are emerging as a cost-effective alternative to hospitals. They provide efficient surgical services with shorter recovery times, attracting a growing segment of patients. As patient awareness increases and technology improves, ASCs are gradually capturing a more significant portion of the market, driven by the demand for more accessible healthcare solutions.</p>

Get more detailed insights about Artificial Heart Market Research Report - Forecast till 2035

Regional Insights

North America : Market Leader in Innovation

North America continues to lead the artificial heart market, holding a significant share of 1290.78M in 2024. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of cardiovascular diseases, and a strong focus on research and development. Regulatory support from agencies like the FDA has accelerated the approval of innovative devices, enhancing market dynamics. The competitive landscape is robust, with key players such as Abbott Laboratories, Medtronic, and Boston Scientific dominating the market. The U.S. remains the largest contributor, benefiting from high healthcare expenditure and a growing aging population. The presence of leading manufacturers fosters innovation and ensures a steady supply of advanced artificial heart technologies.

Europe : Emerging Market with Potential

Europe's artificial heart market is valued at 780.93M, reflecting a growing demand for advanced cardiac solutions. Factors such as an aging population, rising healthcare investments, and increasing awareness of heart diseases are driving market growth. Regulatory frameworks in countries like Germany and France are becoming more supportive, facilitating faster approvals for new technologies. Leading countries include Germany, France, and the UK, where major players like Aortech International and CorWave are making significant strides. The competitive landscape is evolving, with a mix of established companies and innovative startups. The European market is poised for growth as healthcare systems adapt to new technologies and patient needs.

Asia-Pacific : Rapidly Growing Market Segment

The Asia-Pacific region, with a market size of 400.0M, is experiencing rapid growth in the artificial heart sector. Key drivers include increasing urbanization, rising disposable incomes, and a growing prevalence of heart diseases. Governments are investing in healthcare infrastructure, which is expected to enhance access to advanced medical technologies. Regulatory bodies are also working to streamline approval processes for new devices. Countries like Japan, China, and India are leading the charge, with a mix of local and international players entering the market. Companies such as SynCardia Systems and Jarvik Heart are expanding their presence, contributing to a competitive landscape that is becoming increasingly dynamic and innovative.

Middle East and Africa : Emerging Market with Challenges

The Middle East and Africa (MEA) region, valued at 110.84M, presents unique opportunities and challenges in the artificial heart market. Factors such as increasing healthcare investments and a rising prevalence of cardiovascular diseases are driving demand. However, regulatory hurdles and varying healthcare standards across countries can impede growth. Governments are beginning to recognize the importance of advanced cardiac solutions, leading to gradual improvements in regulatory frameworks. Countries like South Africa and the UAE are at the forefront, with a growing number of healthcare facilities adopting advanced technologies. The competitive landscape is still developing, with both local and international players exploring opportunities in this emerging market. The potential for growth is significant as healthcare systems evolve to meet patient needs.

Key Players and Competitive Insights

The Artificial Heart Market is currently characterized by a dynamic competitive landscape, driven by technological advancements and increasing patient demand for innovative cardiac solutions. Key players such as Abbott Laboratories (US), Medtronic (US), and SynCardia Systems (US) are at the forefront, each adopting distinct strategies to enhance their market positioning. Abbott Laboratories (US) focuses on innovation through continuous research and development, aiming to improve the efficacy and longevity of their heart devices. Medtronic (US) emphasizes strategic partnerships and acquisitions to expand its product portfolio and market reach, while SynCardia Systems (US) is dedicated to pioneering advancements in total artificial heart technology, thereby solidifying its niche in the market.

The business tactics employed by these companies include localizing manufacturing to reduce costs and optimize supply chains, which is particularly crucial in a moderately fragmented market. This competitive structure allows for a diverse range of products and solutions, fostering innovation while also presenting challenges in terms of market share distribution. The collective influence of these key players shapes the market dynamics, as they vie for leadership through differentiated offerings and strategic collaborations.

In November 2025, Medtronic (US) announced a groundbreaking partnership with a leading AI technology firm to integrate artificial intelligence into their heart monitoring systems. This strategic move is expected to enhance patient outcomes by providing real-time data analytics, thereby allowing for more personalized treatment plans. The integration of AI not only positions Medtronic as a leader in technological innovation but also reflects a broader trend towards digital transformation in the healthcare sector.

In October 2025, Abbott Laboratories (US) launched a new line of minimally invasive heart pumps designed to cater to a wider range of patients, including those with complex medical histories. This initiative underscores Abbott's commitment to expanding access to life-saving technologies, potentially increasing their market share in the artificial heart segment. The focus on minimally invasive solutions aligns with current healthcare trends that prioritize patient comfort and recovery times.

In September 2025, SynCardia Systems (US) received FDA approval for its latest total artificial heart model, which features enhanced biocompatibility and durability. This approval not only validates SynCardia's innovative approach but also positions the company to capture a larger segment of the market as demand for reliable artificial heart solutions continues to grow. The strategic importance of this approval lies in its potential to significantly improve patient quality of life and reduce long-term healthcare costs.

As of December 2025, the competitive trends in the Artificial Heart Market are increasingly defined by digitalization, sustainability, and the integration of advanced technologies such as AI. Strategic alliances are becoming more prevalent, as companies recognize the need to collaborate in order to leverage complementary strengths. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition towards a focus on innovation, technological advancements, and supply chain reliability. This shift suggests that companies that prioritize research and development, alongside strategic partnerships, will be better positioned to thrive in this rapidly changing market.

Key Companies in the Artificial Heart Market market include

Industry Developments

  • Q2 2024: SynCardia Announces FDA Approval for Next-Generation Total Artificial Heart Market SynCardia Systems received FDA approval for its next-generation Total Artificial Heart Market, designed to improve patient outcomes and device durability. The approval marks a significant milestone for the company and expands treatment options for patients with end-stage heart failure.
  • Q1 2024: Carmat Receives CE Mark Extension for Aeson Artificial Heart Market Carmat announced that it has received an extension of its CE Mark for the Aeson artificial heart, allowing continued commercial sales and use in European markets. The extension supports ongoing adoption of the device for patients with advanced heart failure.
  • Q2 2024: Carmat Resumes Aeson Artificial Heart Market Production After Manufacturing Suspension Carmat resumed production of its Aeson artificial heart following a temporary suspension due to quality control issues. The company implemented corrective actions and received regulatory clearance to restart manufacturing and distribution.
  • Q2 2024: SynCardia Systems Appoints New CEO to Drive Global Expansion SynCardia Systems announced the appointment of a new Chief Executive Officer, aiming to accelerate the company's global expansion and commercialization of its artificial heart technologies.
  • Q1 2024: Carmat Raises €30 Million to Fund Artificial Heart Market Commercialization Carmat completed a €30 million funding round to support the commercialization and scale-up of its Aeson artificial heart in Europe and other markets.
  • Q2 2024: Carmat Signs Distribution Agreement for Aeson Artificial Heart Market in Italy Carmat entered into a distribution agreement with a leading Italian medical device distributor to expand the availability of the Aeson artificial heart in Italy.
  • Q1 2024: FDA Grants Breakthrough Device Designation to BiVACOR Total Artificial Heart Market The FDA granted Breakthrough Device Designation to BiVACOR's Total Artificial Heart Market, recognizing its potential to provide more effective treatment for patients with severe heart failure.
  • Q2 2024: BiVACOR Announces First Human Implantation of Total Artificial Heart Market in U.S. Clinical Trial BiVACOR announced the successful first human implantation of its Total Artificial Heart Market as part of a U.S. clinical trial, marking a major milestone in the development of next-generation artificial heart technology.
  • Q2 2024: Carmat Opens New Manufacturing Facility for Aeson Artificial Heart Market Carmat inaugurated a new manufacturing facility dedicated to the production of its Aeson artificial heart, aiming to increase capacity and meet growing demand in Europe.
  • Q1 2024: SynCardia Systems Expands Distribution Network in Asia-Pacific SynCardia Systems announced the expansion of its distribution network in the Asia-Pacific region, partnering with local medical device companies to increase access to its Total Artificial Heart Market.
  • Q2 2024: Carmat Signs Strategic Partnership with Leading U.S. Cardiac Center Carmat entered into a strategic partnership with a major U.S. cardiac center to advance clinical research and adoption of the Aeson artificial heart in the United States.
  • Q1 2024: BiVACOR Secures $22 Million in Series B Funding to Advance Artificial Heart Market Development BiVACOR raised $22 million in Series B funding to accelerate the development and clinical testing of its Total Artificial Heart Market, supporting ongoing trials and regulatory submissions.

Future Outlook

Artificial Heart Market Future Outlook

<p>The Artificial Heart Market is projected to grow at an 8.92% CAGR from 2024 to 2035, driven by technological advancements, increasing prevalence of heart diseases, and rising healthcare expenditure.</p>

New opportunities lie in:

  • <p>Development of miniaturized artificial hearts for outpatient care</p>
  • <p>Integration of AI for personalized patient monitoring</p>
  • <p>Expansion into emerging markets with tailored financing options</p>

<p>By 2035, the market is expected to achieve substantial growth, driven by innovation and strategic expansion.</p>

Market Segmentation

Artificial Heart Market Type Outlook

  • Total Artificial Heart
  • Partial Artificial Heart
  • Ventricular Assist Device
  • Biventricular Assist Device

Artificial Heart Market End User Outlook

  • Hospitals
  • Ambulatory Surgical Centers
  • Home Care Settings

Artificial Heart Market Application Outlook

  • Cardiac Replacement
  • Cardiac Support
  • Heart Valve Replacement
  • Heart Failure Management

Report Scope

MARKET SIZE 2024 2581.55(USD Million)
MARKET SIZE 2025 2841.4(USD Million)
MARKET SIZE 2035 6635.94(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 8.92% (2024 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Abbott Laboratories (US), Medtronic (US), Boston Scientific (US), Cleveland Heart (US), Carmen Health (US), SynCardia Systems (US), Jarvik Heart (US), Aortech International (GB), CorWave (FR)
Segments Covered Application, Type, End User
Key Market Opportunities Advancements in biocompatible materials enhance performance and patient outcomes in the Artificial Heart Market.
Key Market Dynamics Technological advancements and regulatory changes drive innovation and competition in the Artificial Heart Market.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What was the valuation in 2030?

The valuation was USD 4.98 billion.

What is the predicted CAGR for the Artificial Heart Market for the forecast period (2022-2030)?

The predicted CAGR would be 14.3%.

What could slow down market growth?

The high cost of the procedure and regulations regarding the process can slow down the growth.

Which type to lead the market?

The mechanical heart segment has the chance to record a higher CAGR.

Which region would take charge of the artificial heart market?

The Americas market would dominate the global field.

  1. Definition
    1. Scope of the Study
      1. Research Objective
      2. Assumptions
      3. Limitations
    2. Introduction
    3. Primary Research
    4. Secondary Research
    5. Market Size Estimation
    6. Drivers
    7. Restraints
    8. Opportunities
    9. Challenges
    10. Macroeconomic Indicators
    11. Detection Technique Trends & Assessment
    12. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
    13. Value Chain Analysis
    14. Investment Feasibility Analysis
    15. Pricing Analysis
  2. Chapter 6. Global Artificial Heart Market, by Type
    1. Introduction
    2. Heart-Lung Machine
  3. Market Estimates & Forecast, by Region, 2020-2027
  4. Market Estimates & Forecast, by Country, 2020-2027
    1. Mechanical Heart
  5. Market Estimates & Forecast, by Region, 2020-2027
  6. Market Estimates & Forecast, by Country, 2020-2027
  7. Total Artificial Hearts
  8. Market Estimates & Forecast, by Region, 2020-2027
  9. Market Estimates & Forecast, by Country, 2020-2027
  10. Ventricular Assist Devices (VADs)
  11. Market Estimates & Forecast, by Region, 2020-2027
  12. Market Estimates & Forecast, by Country, 2020-2027
  13. Chapter 7. Global Artificial Heart Market, by End User
    1. Introduction
    2. Hospitals & Clinics
  14. Market Estimates & Forecast, by Region, 2020-2027
  15. Market Estimates & Forecast, by Country, 2020-2027
    1. Specialty Centers
  16. Market Estimates & Forecast, by Region, 2020-2027
  17. Market Estimates & Forecast, by Country, 2020-2027
    1. Others
  18. Market Estimates & Forecast, by Region, 2020-2027
  19. Market Estimates & Forecast, by Country, 2020-2027
  20. Chapter 8. Global Artificial Heart Market, by Region
    1. Introduction
    2. Americas
      1. North America
      2. Latin America
    3. Europe
      1. Western Europe
      2. Eastern Europe
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
      4. Australia
      5. South Korea
      6. Rest of Asia-Pacific
    5. Middle East & Africa
      1. Middle East
      2. Africa
    6. Chapter 9 Company Landscape
    7. Introduction
    8. Market Share Analysis
    9. Key Development & Strategies
    10. Chapter 10. Company Profiles
    11. SynCardia Systems, LLC
      1. Company Overview
      2. Treatment Overview
      3. Financials Overview
      4. Key Developments
      5. SWOT Analysis
    12. BiVACOR Inc.
      1. Company Overview
      2. Treatment Overview
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
    13. CARMAT
      1. Company Overview
      2. Treatment Overview
      3. Financial Overview
      4. Key Development
      5. SWOT Analysis
    14. Cleveland Heart, Inc.
      1. Company Overview
      2. Treatment Overview
      3. Financial Overview
      4. Key Development
      5. SWOT Analysis
    15. ABIOMED
      1. Company Overview
      2. Treatment Overview
      3. Financial overview
      4. Key Developments
      5. SWOT Analysis
    16. CryoLife, Inc.
      1. Company Overview
      2. Treatment Overview
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
    17. Abbott
      1. Company Overview
      2. Treatment Overview
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
    18. Thoratec Corporation
      1. Company Overview
      2. Treatment Overview
      3. Financials
      4. Key Developments
      5. SWOT Analysis
    19. Chapter 11 MRFR Conclusion
    20. Key Findings
      1. From CEO’s Viewpoint
      2. Unmet Needs of the Market
    21. Key Companies to Watch
    22. Predictions for the Artificial Heart Industry
    23. Chapter 12. Appendix
  21. LIST OF TABLES
  22. Global Artificial Heart Market Synopsis, 2020-2027
  23. Global Artificial Heart Market Estimates and Forecast, 2020-2027
    1. (USD Million)
  24. Global Artificial Heart Market, by Region, 2020-2027 (USD Million)
  25. Global Artificial Heart Market, by Type, 2020-2027 (USD Million)
  26. Global Artificial Heart Market, by End-User, 2020-2027 (USD
    1. Million)
  27. North America: Artificial Heart Market, by Type, 2020-2027 (USD
    1. Million)
  28. North America: Artificial Heart Market, by End User, 2020-2027
    1. (USD Million)
  29. US: Artificial Heart Market, by Type, 2020-2027 (USD Million)
  30. US: Artificial Heart Market, by End User, 2020-2027 (USD
    1. Million)
  31. Canada: Artificial Heart Market, by Type, 2020-2027 (USD Million)
  32. Canada: Artificial Heart Market, by End User, 2020-2027 (USD
    1. Million)
  33. Latin America: Artificial Heart Market, by Type, 2020-2027 (USD
    1. Million)
  34. Latin America: Artificial Heart Market, by End User, 2020–
  35. Europe: Artificial Heart Market, by Type, 2020-2027 (USD Million)
  36. Europe: Artificial Heart Market, by End User, 2020-2027 (USD
    1. Million)
  37. Western Europe: Artificial Heart Market, by Type, 2020-2027 (USD
    1. Million)
  38. Western Europe: Artificial Heart Market, by End User, 2020–
  39. Eastern Europe: Artificial Heart Market, by Type, 2020-2027 (USD
    1. Million)
  40. Eastern Europe: Artificial Heart Market, by End User, 2020–
  41. Asia-Pacific: Artificial Heart Market, by Type, 2020-2027 (USD
    1. Million)
  42. Asia-Pacific: Artificial Heart Market, by End User, 2020-2027
    1. (USD Million)
  43. Middle East & Africa: Artificial Heart Market, by Type, 2020-2027
    1. (USD Million)
  44. Middle East & Africa: Artificial Heart Market, by End User,
  45. LIST OF FIGURES
  46. Research Process
  47. Segmentation for Global Artificial Heart Market
  48. Segmentation Market Dynamics for Global Artificial Heart Market
  49. Global Artificial Heart Market Share, by Type, 2020
  50. Global Artificial Heart Market Share, by End User, 2020
  51. Global Artificial Heart Market Share, by End User, 2020
  52. Global Artificial Heart Market Share, by Region, 2020
  53. North America: Artificial Heart Market Share, by Country, 2020
  54. Europe: Artificial Heart Market Share, by Country, 2020
  55. Asia-Pacific: Artificial Heart Market Share, by Country, 2020
  56. Middle East & Africa: Artificial Heart Market Share, by Country, 201
  57. Global Artificial Heart Market: Company Share Analysis, 2020 (%)
  58. SynCardia Systems, LLC: Key Financials
  59. SynCardia Systems, LLC.: Segmental Revenue
  60. SynCardia Systems, LLC: Geographical Revenue
  61. BiVACOR Inc.: Key Financials
  62. BiVACOR Inc.: Segmental Revenue
  63. BiVACOR Inc.: Geographical Revenue
  64. CARMAT: Key Financials
  65. CARMAT: Segmental Revenue
  66. CARMAT: Geographical Revenue
  67. ABIOMED: Key Financials
  68. ABIOMED: Segmental Revenue
  69. ABIOMED.: Geographical Revenue

Artificial Heart Market Segmentation

Market Segmentation Overview

  • Detailed segmentation data will be available in the full report
  • Comprehensive analysis by multiple parameters
  • Regional and country-level breakdowns
  • Market size forecasts by segment
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓